Tel Aviv University researchers successfully 3D bioprinted an active tumour to achieve a scientific breakthrough in battle against cancer.
Tel Aviv University’s technology transfer company Ramot, announced recently, that it has signed a collaboration agreement with Bayer, a German pharmaceutical multinational, to develop and test new cardiac drugs using 3D printed human heart tissues.
[penci_blockquote style=”style-1″ align=”none” author=””]Tel Aviv University scientists take a major step towards a future where hearts can be 3D printed for transplants…
